SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-062594
Filing Date
2019-11-12
Accepted
2019-11-12 16:02:23
Documents
64
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm1919554-1_10q.htm 10-Q 774768
2 EXHIBIT 31.1 tm1919554d1_ex31-1.htm EX-31.1 11099
3 EXHIBIT 31.2 tm1919554d1_ex31-2.htm EX-31.2 11101
4 EXHIBIT 32.1 tm1919554d1_ex32-1.htm EX-32.1 5346
5 EXHIBIT 32.2 tm1919554d1_ex32-2.htm EX-32.2 4181
6 GRAPHIC tm1919554-1_10qimg01.jpg GRAPHIC 11849
7 GRAPHIC tm1919554-1_10qimg02.jpg GRAPHIC 115951
  Complete submission text file 0001104659-19-062594.txt   4059872

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT mrkr-20190930.xml EX-101.INS 938002
9 XBRL TAXONOMY EXTENSION SCHEMA mrkr-20190930.xsd EX-101.SCH 39194
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mrkr-20190930_cal.xml EX-101.CAL 33463
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrkr-20190930_def.xml EX-101.DEF 72319
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrkr-20190930_lab.xml EX-101.LAB 237114
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrkr-20190930_pre.xml EX-101.PRE 195333
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37939 | Film No.: 191209201
SIC: 2834 Pharmaceutical Preparations